Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

NCT02536404 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Etrasimod
DRUG: Placebo

Sponsor

Arena Pharmaceuticals